Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease
PaperCitations, authors & open-access status
Revolutionary breakthrough: FDA approves CASGEVY, the first CRISPR/Cas9 gene therapy for sickle cell disease is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 87 citations, 2024 year and gold oa status.
87
Citations
2024
Year
gold
OA Status